中文摘要：

目的：评价二极管激光经巩膜睫状体光凝治疗新生血管性青光眼的疗效。方法：对52例诊断为新生血管性青光眼的患者行经巩膜的810nm激光睫状体光凝,能量为1500~3000mW,时间2000ms,范围为24~32点,随访1a,观察其治疗效果。结果：治疗前眼压为（57.78±6.46）mmHg,治疗3d后眼压为（30.8±5.41）mmHg,与治疗前相比,差异显著;随访1a后眼压为（19.44±4.38）mmHg,与治疗前相比,差异显著。所有患者的疼痛均得到缓解或消除。结论：经巩膜睫状体光凝治疗新生血管性青光眼是有效和安全的。

英文摘要：

AIM ： To evaluate the efficacy of transscleral diode laser cyclophotocoagulation for eyes with neovascular glaucoma. METHODS： Fifty-two eyes with neovascular glaucoma underwent transscleral diode laser cyclophotocoagulation with energy of 1500-3000mW applied for 2000ms. The therapeutic point was from 24 to 32. The patients were followed one year. RESULTS： The mean pretreatment intraocular pressure （lOP） was 57.78 ± 6.46mmHg. On the third day after laser treatment, the lOP was （30.8 ± 5.41 ） mmHg （P 〈 0. 05）. A year later, the lOP was （ 19.44 ± 4.38） mm Hg （ P 〈 0.05）. In all patients the pain relieved. CONCLUSION： Diode laser contact transscleral cyclophotocoagulation is a safe and effective therapeutic method to neovascular glaucoma.